Medicine and Dentistry
Neonates
100%
Bacterial Infection
70%
Neonatal Sepsis
66%
Randomized Clinical Trial
66%
Sepsis
49%
Antibiotics
43%
Blood Culture
42%
Systematic Review
33%
Noninferiority Trial
33%
Personalized Medicine
33%
Polymerase Chain Reaction
33%
Prospective Cohort Study
33%
Antibiotic Therapy
24%
Randomized Controlled Trial
23%
Laboratory Test
14%
Meta-Analysis
14%
Diseases
13%
Streptococcus Agalactiae
13%
Intention-to-Treat Analysis
11%
Reinfection
11%
Escherichia coli
10%
Infection
8%
Adverse Event
7%
Immune Response
6%
Pharmacokinetics
6%
Clinician
6%
Newborn Period
6%
Disease Severity
6%
Patient Characteristics
6%
Disease Predisposition
6%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Clavulanic Acid
71%
Amoxicillin
51%
Bacterial Infection
40%
Beta Lactamase
33%
Antibiotics
33%
Noninferiority Trial
33%
Reinfection
14%
Adverse Event
9%
Antibiotic Therapy
9%
Diseases
8%
Bioavailability
6%
Prematurity
6%
